Cantor Fitzgerald Reiterates Overweight on Eli Lilly, Maintains $630 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly (LLY) and maintained a price target of $630.
February 05, 2024 | 4:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen reaffirmed an Overweight rating on Eli Lilly, with a price target of $630.
The reiteration of an Overweight rating and a high price target of $630 by a reputable analyst could positively influence investor sentiment towards Eli Lilly, potentially driving up its stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100